MHRA launches new programme to tackle evidence gaps on women’s health
Safety Classified by Officially
Women are set to benefit from better evidence on medicines and medical devices, including how their risks and benefits may differ for women, under a new programme launched today by the Medicines and Healthcare products Regulatory Agency (MHRA).
Despite making up 51% of the population, women continue to face gaps in research and treatment across a range of health conditions. They have historically been underrepresented in clinical research, limiting the evidence available on medicines and medical devices during pregnancy and across reproductive health. Unmet needs also remain for conditions specific to women, as well as those that present differently or disproportionately in women.
An MHRA analysis of all 4,616 UK clinical trial applications submitted between 2019 and 2023 highlighted continuing gaps in representation. Pregnant women were represented in just 1.1% of trials, while breastfeeding women were represented in 0.6%.
The Women’s Health Programme aims to address these challenges and explore how better data and scientific advancements can more accurately reflect women’s needs.
Women’s Health Minister, Baroness Gillian Merron, said:
“For too long, women’s health has been overlooked. Women make up more than half of our population, yet they have been underrepresented in the research that shapes the medicines and devices they rely on. That is not good enough, and we are determined to change it.
“This new programme is a welcome step. Together with our renewed Women’s Health Strategy, it will mean better evidence, better treatments, and a health system that listens to women and works for them.”
Lawrence Tallon, MHRA Chief Executive, said:
“Closing the gaps in our understanding of how the risks and benefits of medicines and medical devices differ for women is both a challenge and a huge opportunity.
This is an extract. The publication continues at the source.
Contains public sector information licensed under the Open Government Licence v3.0. Licence
Read the original at the source: https://www.gov.uk/government/news/mhra-launches-new-programme-to-tackle-evidence-gaps-on-womens-health
Officially imported this from Medicines and Healthcare products Regulatory Agency’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Medicines and Healthcare products Regulatory Agency — imported from official source
- Official source
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency.atom ATOM
- Imported
- November 16, 2026 09:00
- Versions
- 1 recorded
- Identity
-
https://www.gov.uk/government/news/mhra-launches-new-programme-to-tackle-evidence-gaps-...